The platelets’ perspective to pathogen reduction technologies
A wide variety of clinical conditions, associated with low circulating platelet counts, require platelet transfusion in order to normalize hemostatic function. Although single-donor apheresis platelets bear the lowest risk of transfusion-transmitted infections, pathogen reduction technologies (PRT)...
Main Authors: | Abdimajid Osman, Walter E. Hitzler, Patrick Provost |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-02-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2017.1293806 |
Similar Items
-
Pathogen reduction technologies: The pros and cons for platelet transfusion
by: Audrey Magron, et al.
Published: (2018-01-01) -
Pathogen Reduction for Platelets—A Review of Recent Implementation Strategies
by: Paolo Rebulla, et al.
Published: (2022-01-01) -
INTERCEPT Pathogen Reduction in Platelet Concentrates, in Contrast to Gamma Irradiation, Induces the Formation of <i>trans</i>-Arachidonic Acids and Affects Eicosanoid Release during Storage
by: Gerda C. Leitner, et al.
Published: (2022-09-01) -
Platelet Transfusion—Insights from Current Practice to Future Development
by: Annina Capraru, et al.
Published: (2021-05-01) -
The amazing genetic complexity of anucleated platelets
by: Loredana Bury, et al.
Published: (2022-07-01)